AAAAI 2021 Research Suggests No Raised Risk of COVID-19 Severity with Asthma
A review of 3 new studies, which indicate the association between severe COVID-19 and the chronic disease is more intricate than previously thought.
Diverse Eosinophilic Esophagitis Symptoms and Care Teams
How dupilumab is observed to benefit EoE patients—and who may administer the biologic therapy.
Tezepelumab Benefits Severe, Uncontrolled Asthma in Phase 3 NAVIGATOR Findings
An interview on the TSLP inhibitor's effect on exacerbations, hospitalizations, and disease progress over 52-week findings.
Dupilumab for Eosinophilic Esophagitis
Perspective on how the interleukin-targeting biologic has unique benefit for the rare, under-resourced disease.
Welcome to Rare Disease Day: An Interview with a NORD Representative
Lisa Sarfaty, director of strategic planning for the National Organization for Rare Disorders, speaks on the role of the organization and the importance of the Rare Disease Day campaign.
Breathing Difficulty Still Common in Hospitalized COVID-19 Patients After 6 Months
New survey results depict unexpected burdens in long-haul patients, as well as continued issues following rehabilitation.
PONENTE: Benralizumab Reduces Oral Corticosteroid Use in Severe Asthmatics
An interview with a study author on new interpretations of biologic asthma benefit.
PALFORZIA at 3 Years: New Data Show Sustained Peanut Immunotherapy Benefit, Safety
A discussion on continued research into the first regulated treatment for pediatric peanut allergy.
The Current Challenges of Psoriasis Prescribing
Maintaining Biologic Adherence
Involuntary Biologic Switches: Long-Term Impact
The Risks of Switching Psoriasis Biologics During COVID-19
Outcomes Linked to Psoriasis Biologic Switches
Waqar Khan, MD: Coronary Heart Disease During COVID-19
Unhealthy lifestyles during the pandemic may increase the risk of cardiovascular disease.
Caterina Minniti, MD: Challenges Associated with Sickle-Cell Related Leg Ulcers
Due to taboo or stigma, patients may not openly discuss their leg ulcers with their providers.
Caterina Minniti, MD: Leg Ulcers in Sickle Cell Patients
An expert discusses findings that showed voxelotor (Oxbryta) improved leg ulcers in patients with sickle cell disease.
Waqar Khan, MD, MPH: The Importance of Coronary Heart Disease Awareness
Dr. Khan discusses some of the risk factors associated with CHD.
Acute Coronary Syndrome Management with Antithrombotics
A Stanford Cardiovascular Institute expert details a recent review into managing a growing field of agents.
Advice to Primary Care Providers: Recognizing MIS-C
Two pediatric cardiologists stress that recognizing symptoms of MIS-C is essential for primary care providers.
Talking with Parents about Multisystem Inflammatory Syndrome in Children
Two pediatric cardiologists offer perspective on how to approach conversations about MIS-C with parents or guardians.
Understanding Multisystem Inflammatory Syndrome in Children
Dongngan Truong, MD, and Jane Newburger, MD, discuss the current clinical understanding of MIS-C.
National Wear Red Day: Perspectives on Women's Cardiovascular Health
Two experts offer perspectives on the importance and state of cardiovascular health in women.
How DBV Intends to Assess its Peanut Immunotherapy Patch Long-term
Pending FDA decision, the Viaskin Peanut patch would be considered for lengthier benefit studies.
Multidisciplinary Management of Atopic Dermatitis
What Goes Into Asthma Management Guidelines
Anne Dixon, MD, explains how it took 6 years to update recommendations for new asthma therapies.
Advice on Collaborative Care for Atopic Dermatitis
Approaching Management of Atopic Dermatitis
Impact of Atopic Dermatitis on Patients and Caregivers
An Overview of Atopic Dermatitis
Pharis Mohideen, MD, MS: Updates on the Viaskin Peanut Patch
The epicutaneous immunotherapy for peanut allergy is continuing discussions with the FDA. What is its potential in allergic care?
